AURA Aura Biosciences Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: AURA

Price (delayed)

$7.65

Market cap

$793.34M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.75

Enterprise value

$741.33M

?
Relative Growth: Rel. Growth: 6
Relative Strength: Rel. Strength: 58
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 4
Highlights
AURA's equity has surged by 194% since the previous quarter and by 81% year-on-year
AURA's quick ratio has soared by 140% from the previous quarter and by 38% YoY
The company's net income fell by 29% YoY and by 17% QoQ
Sector: Healthcare
Industry: Biotechnology
Website: https://www.aurabiosciences.com
Peers: AMGN GILD VRTX REGN

Key stats

What are the main financial stats of AURA

AURA stock price

How has the Aura Biosciences stock price performed over time
Intraday
-1.29%
1 week
-0.91%
1 month
9.29%
1 year
5.81%
YTD
40.37%
QTD
7.75%

Financial performance

How have Aura Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$138.08M
Net income
-$131.01M
Gross margin
N/A
Net margin
N/A
The company's net income fell by 29% YoY and by 17% QoQ
AURA's operating income is down by 27% year-on-year and by 16% since the previous quarter

Price vs fundamentals

How does AURA's price correlate with its fundamentals

Growth

What is Aura Biosciences's growth rate over time

Valuation

What is Aura Biosciences stock price valuation
P/E
N/A
P/B
2.51
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Aura Biosciences's EPS has increased by 11% YoY
AURA's equity has surged by 194% since the previous quarter and by 81% year-on-year
AURA's price to book (P/B) is 10% less than its last 4 quarters average of 2.8 and 3.5% less than its 5-year quarterly average of 2.6

Efficiency

How efficient is Aura Biosciences business performance
AURA's return on invested capital is down by 25% year-on-year but it is up by 19% since the previous quarter
Aura Biosciences's return on equity has decreased by 14% YoY but it has increased by 6% QoQ
The return on assets has declined by 14% year-on-year but it has grown by 3.3% since the previous quarter

Dividends

What is AURA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AURA.

Financial health

How did Aura Biosciences financials performed over time
Aura Biosciences's total assets has surged by 153% QoQ and by 70% YoY
AURA's quick ratio has soared by 140% from the previous quarter and by 38% YoY
AURA's debt is 95% less than its equity
AURA's equity has surged by 194% since the previous quarter and by 81% year-on-year
The debt to equity has dropped by 69% since the previous quarter and by 50% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.